Study guide

OCT and automated perimetry

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

OCT and automated perimetry

Key Takeaways Explain This Topic AI

Inspect actual OCT scans for segmentation and myopic artifacts rather than accepting colour coding alone.

Macular ganglion-cell and peripapillary RNFL analysis provide complementary structural information.

Automated fields depend on suitable strategy, correction, fixation and patient cooperation.

Last updated: October 2026

2. Spectral-Domain Optical Coherence Tomography (SD-OCT)

Optical Coherence Tomography (SD-OCT) utilizes low-coherence near-infrared interferometry (wavelength λ ≈ 840 nm \lambda \approx 840\text{ nm} λ ≈ 840 nm ) to acquire cross-sectional architectural tomograms of retinal microstructures with axial resolutions of 3 to 5 μ m 3\text{ to }5\,\mu\text{m} 3 to 5 μ m .

1. Peripapillary Retinal Nerve Fibre Layer (pRNFL) Profiling

Acquisition : Peripapillary scan diameter and segmentation depend on the device. Check centration, signal, artefacts and the same-device longitudinal comparison.

The TSNIT Curve: In healthy eyes, pRNFL thickness displays a classic bimodal "double-hump" distribution along the Temporal → \to → Superior → \to → Nasal → \to → Inferior → \to → Temporal (TSNIT) trajectory:

The superior and inferior humps (normal thickness 110 – 135 μ m 110–135\,\mu\text{m} 110–135 μ m ) correspond to dense convergent bundles of arcuate axons entering the vertical poles.

Glaucomatous damage presents as flattening, notching, or complete collapse of the superior and/or inferior peaks.

Normative Database Color-Coding:

Green ( p = 5 % – 95 % p = 5\%–95\% p = 5%–95% ): Within normal limits.

Yellow ( p < 5 % p < 5\% p < 5% ): Borderline thinning.

Red ( p < 1 % p < 1\% p < 1% ): Outside normal limits (statistically significant structural loss).

2. Macular Ganglion Cell Analysis (GCIPL / GCC)

Over 50 % 50\% 50% of all retinal ganglion cell bodies are concentrated within the central 4.5 mm 4.5\text{ mm} 4.5 mm of the macula, where the RGC layer forms a dense band up to 6 6 6 cells thick:

Parameters Measured: Depending on the OCT platform:

GCIPL (Ganglion Cell-Inner Plexiform Layer): Segments the RGC cell bodies (GCL) and their dendrites (IPL), excluding the variable nerve fiber layer.

GCC (Ganglion Cell Complex): Segments three layers: RNFL + GCL + IPL \text{RNFL} + \text{GCL} + \text{IPL} RNFL + GCL + IPL .

Complementary macular analysis: Ganglion-cell measurements can help identify paracentral damage alongside peripapillary RNFL and fields. High myopia, staphyloma, macular disease and segmentation errors can affect both methods. Inspect the actual scans and longitudinal change rather than assuming macular analysis is uniformly more reproducible in every high myope.

3. The Structural Floor Effect

In advanced glaucoma, global RNFL measurements may approach a device-dependent measurement floor because residual non-neural tissue and surviving axons contribute to thickness. A stable global number does not prove stability or that all axons have died. Inspect the remaining measurable sectors, macular ganglion-cell scans and segmentation quality, together with fields and disc examination. A 10-2 field can sample central function densely; choose grids by the defect and avoid switching the whole monitoring strategy solely because of one RNFL value.

3. Standard Automated Perimetry (SAP): Humphrey Field Analyzer (HFA)

Standard Automated Perimetry (SAP) is the clinical gold standard for quantifying visual function in glaucoma. It measures differential light sensitivity across the central and peripheral visual field using static white-on-white automated testing.

Physical & Optical Principles of the HFA

Stimulus Parameters: A common SAP stimulus is Goldmann size III, subtending about 0.43 ∘ 0.43^\circ 0.4 3 ∘ , with a brief presentation of about 200 ms 200\text{ ms} 200 ms . A white stimulus is presented on a standard bowl background. Brief presentation reduces opportunities for refixation, but saccadic latency varies; fixation monitoring and artefact review remain necessary.

Background Luminance: Maintained at 31.5 apostilbs (asb) 31.5\text{ apostilbs (asb)} 31.5 apostilbs (asb) (equivalent to 10 cd/m 2 10\text{ cd/m}^2 10 cd/m 2 ). This places retinal adaptation in the photopic/upper mesopic range where Weber's law of contrast sensitivity operates: Δ I I = Constant \frac{\Delta I}{I} = \text{Constant} I Δ I ​ = Constant

The Decibel Scale ( dB \text{dB} dB ): Retinal sensitivity is quantified on a logarithmic decibel scale: Sensitivity (dB) = 10 × log ⁡ 10 ( I max Δ I ) \text{Sensitivity (dB)} = 10 \times \log_{10} \left( \frac{I_{\text{max}}}{\Delta I} \right) Sensitivity (dB) = 10 × lo g 10 ​ ( Δ I I max ​ ​ ) where I max = 10 , 000 asb I_{\text{max}} = 10,000\text{ asb} I max ​ = 10 , 000 asb (the maximum light intensity delivered by the perimeter projection system):

0 dB 0\text{ dB} 0 dB represents maximum brightness ( 10 , 000 asb 10,000\text{ asb} 10 , 000 asb , meaning the patient can only perceive an intensely blinding light flash).

30 to 35 dB 30\text{ to }35\text{ dB} 30 to 35 dB represents a normal central retinal threshold (the patient can detect an extremely dim stimulus of ≈ 10 asb \approx 10\text{ asb} ≈ 10 asb ).

50 dB 50\text{ dB} 50 dB represents the theoretical limit of maximum sensitivity ( 0.1 asb 0.1\text{ asb} 0.1 asb ). A change of 10 dB 10\text{ dB} 10 dB represents a 10 10 10 -fold (one log unit) shift in retinal light sensitivity.

Perimetric Testing Protocols

SITA-Standard (Swedish Interactive Thresholding Algorithm): Uses sophisticated Bayesian probability models based on extensive normative datasets. By updating prior probabilities based on responses to neighbouring test points, it cuts testing time to 4 to 6 minutes 4\text{ to }6\text{ minutes} 4 to 6 minutes per eye while preserving maximal test-retest reproducibility.

SITA-Fast: Employs wider step sizes and abbreviated Bayesian algorithms, shortening test duration to 2 to 3 minutes 2\text{ to }3\text{ minutes} 2 to 3 minutes per eye . Useful in tired, elderly, or easily fatigued patients, though with slightly higher measurement variability.

SITA-Faster: Eliminates blind-spot catch trials and false-negative trials entirely (monitoring fixation via automated corneal gaze tracking), reducing test time by an additional 30 % 30\% 30% .

Standard Testing Grids: 24-2, 30-2, and 10-2

Grid Pattern Total Test Points Spatial Separation Eccentricity Covered Clinical Application & Pearls

24-2 Grid 54 points 6 ∘ 6^\circ 6 ∘ grid spacing 24 ∘ 24^\circ 2 4 ∘ temporally, 30 ∘ 30^\circ 3 0 ∘ nasally Current standard workhorse ; tests two extra points above and below the horizontal midline nasally to detect early nasal steps.

30-2 Grid 76 points 6 ∘ 6^\circ 6 ∘ grid spacing 30 ∘ 30^\circ 3 0 ∘ in all quadrants High rate of peripheral edge rim artefacts from trial frames; induces patient fatigue and may add information in neuro-ophthalmic or more peripheral defects.

10-2 Grid 68 points 2 ∘ 2^\circ 2 ∘ grid spacing Central 10 ∘ 10^\circ 1 0 ∘ macula Critical for central vision ; the 6 ∘ 6^\circ 6 ∘ spacing of the 24-2 grid leaves wide gaps that can completely miss dense macular scotomas. Indicated when paracentral defects appear on 24-2 or in advanced disease.